Pharmacovigilance information collected through post-authorization surveillance systems is used to change drug labeling and update benefit:risk profile of marketed drugs.…
Modern Oncology Therapies
Review of novel biological cancer therapies and exploration of ways that would make them locally available within the context of…
CYP2D6 and CYP3A4 in opioid metabolism: Time to develop guidance for PGX biomarkers?
Clinically relevant insight into genetic makeup and phenotypic biomarkers, such as ADMET and treatment outcomes, would significantly improve predictability of…
Essential medicines in Hungary
The business case for more robust pre-clinical research
In the high consequence environment of pharmaceutical development, any assumption made earlier in the process can prove extremely costly if…
Personal data protection in the EU
GXP Inspection readiness
Clinical Evaluation of Medical Devices
The Internet of Pharmaceuticals
In the current, increasingly complex and interconnected world, timely and accurate information on the operational environment, and the presence of…
Availability of Essential Medicines in the Czech Republic
The Czech Republic is a small market with a complex regulatory environment and inconsistently applied and enforced rules that often…
